<![CDATA[Improving Luspatercept Titration and Persistence in Community Practice]]>

A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia

Conditions : Myelodysplastic Syndromes; Beta-thalassemia Interventions : Drug: Luspatercept Sponsors : Bristol-Myers Squibb Terminated

<![CDATA[Pharmacist-Led Workflows Support Safe Outpatient BiTE Therapy in Multiple Myeloma]]>

Register Now: Reproducibility Under Pressure — Automating Impurity Testing in Biotherapeutic Development

<![CDATA[Pharmacists and Continuous Glucose Monitoring: An Attachment Worth Having]]>

<![CDATA[The Proactive Pharmacist: Building Menopause Knowledge and Closing Care Gaps in the Community]]>

A generalist precision medication framework using temporal causal inference based on treatment-free physiological profiles

Unlock personalized treatments! TCPM framework transforms routine physiological data into precise strategies, improving outcomes with unobse